Does Polivy Provide A Cure For DLBCL? Too Early To Say, Argue NICE Experts
A Draft 'No' To Roche’s Lymphoma Contender
Roche receives initial knockback for lymphoma treatment which could rival CAR-T therapies.
You may also be interested in...
Novartis has accelerated its digital ambitions during the worldwide lockdown period, working with partners such as Doximity on engaging doctors and Science 37 on virtual trial tech.
Pharma will oppose a patent pool, but the world still needs a way to guarantee fair access to COVID-19 vaccines.
While Moderna and others frontrunners aim for a 2020 emergency use approval, Merck believes a more deliberate approach will pay off in the long term.